Table 3.

Correlation between expression of DVL2 and clinicopathological features of patients with CRC

Variable	Low DVL2	High DVL2	P-value
Sex			0.161
Male	44 (62.0%)	32 (50.0%)
Female	27 (38.0%)	32 (50.0%)
Median age (years)			0.129
<66	30 (42.3%)	19 (29.7%)
≥66	41 (57.7%)	45 (70.3%)
Clinical stage			0.003**
I–II	54 (76.1%)	33 (51.6%)
III–IV	17 (23.9%)	31 (48.4%)
pT status			0.123
T1–T2	5 (7.0%)	1 (1.6%)
T3–T4	66 (93.0%)	63 (98.4%)
pN status			0.003**
N0	57 (80.3%)	36 (56.3%)
N1–N2	14 (19.7%)	28 (43.8%)
pM status			0.057
M0	67 (94.4%)	54 (84.4%)
M1	4 (5.6%)	10 (15.6%)
Disease progression			0.038*
No	54 (76.1%)	38 (59.4%)
Yes	17 (23.9%)	26 (40.6%)

^* P < 0.05;

^** P < 0.01;

^*** P < 0.001.

CRC, colorectal cancer; T, tumor; N, node; M, metastasis.